In the arthrogryposis multiplex congenita model, the administration of FcRn antagonist to pregnant dams infused with human acetylcholine receptor-specific antibodies resulted in nearly significant decreases in pathogenic antibodies in the dams, and a major decrease of these antibodies in the fetuses 239 .
1
—
—